Anthony Chalmers

Anthony is Chair of Clinical Oncology at the University of Glasgow and Director of the CRUK RadNet Centre of Excellence in Radiotherapy Research. He has a clinical neuro-oncology practice at the Beatson West of Scotland Cancer Centre and runs the Translational Radiation Biology laboratory in the Institute for Cancer Sciences. His main research interest is in improving outcomes for patients with glioblastoma by combining radiotherapy with targeted drug therapy, but his research interest in radiotherapy-drug combinations extends across tumor sites. He is the Chief Investigator for a portfolio of early-phase clinical trials evaluating novel DNA damage response (DDR) inhibitors in combination with radiotherapy in patients with glioblastoma. He was Chair of the NCRI Clinical and Translational Radiotherapy Research Working Group (CTRad) from 2016-19 and currently co-chairs the CRUK RadNet Radiotherapy-Drug Combinations Working Group. He sits on the Executive Board of the European Association for Neuro-Oncology (EANO) and the Radiobiology Committee of the European Society for Therapeutic Radiation Oncology (ESTRO). Since arriving in Glasgow in 2010 he has established the Scottish Radiotherapy Research Forum and is currently Vice-Chair of the Radiotherapy Programme Board in Scotland. He is currently a member of the Medical Research Council Molecular and Cellular Medicine Board.